4 Stocks Under Rs 100 Where Q2 FY27 Profit More Than Doubled: Manali Petrochemicals, IDFC First Bank, Morepen and SJVN
- November 20, 2026
- Posted by: Ankit Jaiswal
- Category: Market
Q2 FY27 profit growth: Manali 249.9%, IDFC First 201.7%, Morepen 116.6%, SJVN 113.7% (results to 30 Sep 2026). All priced under Rs 100.
Quick Answer
Manali Petrochemicals, IDFC First Bank, Morepen Laboratories and SJVN are four stocks under Rs 100 whose Q2 FY27 profit more than doubled year-on-year. Manali’s rose 249.9%, IDFC First Bank’s 201.7%, Morepen’s 116.6% and SJVN’s 113.7%. Revenue also grew strongly at all four, between 20.3% and 112.4%, which shows the gains came from business growth. A single quarter is a starting signal, so the next two results will show whether the momentum holds.
Quarterly results are the most direct way to see which companies are gaining momentum. When profit more than doubles on rising revenue, it often marks a shift in demand, pricing or capacity.
The four stocks below reported a Q2 FY27 profit more than twice the level of the September 2025 quarter, with revenue growth above 20%, and all trade under Rs 100. Prices are as of the 19 November 2026 NSE close, and financials are from company exchange filings.
Click Here – Get Free Investment Predictions
Which Stocks Under Rs 100 Doubled Their Q2 FY27 Profit?
Manali Petrochemicals (249.9%), IDFC First Bank (201.7%), Morepen Laboratories (116.6%) and SJVN (113.7%) are four stocks under Rs 100 whose Q2 FY27 profit more than doubled from a year earlier. Each also grew revenue by at least 20%.
| Company | Sector | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE | Debt-to-Equity |
|---|---|---|---|---|---|---|---|
| Manali Petrochemicals | Petrochemicals | 77.70 | 1,331 | 5.91 | 11.02 | 11.58% | 0.09 |
| IDFC First Bank | Private Bank | 86.05 | 74,290 | 24.74 | 13.15 | 6.11% | Not applicable (bank) |
| Morepen Laboratories | Pharmaceuticals | 90.55 | 4,967 | 26.35 | 40.13 | 13.65% | 0.23 |
| SJVN | Hydro and Renewable Power | 56.20 | 22,085 | 22.30 | 20.23 | 6.60% | 2.25 |
IDFC First Bank is the largest of the four at Rs 74,290 crore in market capitalisation, while Manali Petrochemicals is the smallest at Rs 1,331 crore. Manali also has the lowest P/E at 5.91.
1. Manali Petrochemicals: Q2 FY27 Profit Up 249.9%
Manali Petrochemicals reported Q2 FY27 profit of Rs 63.50 crore, up 249.9% from Rs 18.15 crore, as revenue rose 58.8% to Rs 414.37 crore. Operating margin nearly doubled to 24.73% from 12.99%, showing better pricing for its products.
The company makes propylene oxide, propylene glycol and polyols for foams, pharma and food uses. FY26 profit had already risen 343.4% to Rs 129.95 crore. At Rs 77.70 the stock trades at a P/E of 5.91 and 0.94 times book value, with a debt-to-equity ratio of 0.09. Product prices are cyclical, so margins may not stay at this level every quarter.
2. IDFC First Bank: Q2 FY27 Profit Up 201.7%
IDFC First Bank’s Q2 FY27 profit rose 201.7% to Rs 1,049.17 crore from Rs 347.80 crore, while revenue rose 20.3% to Rs 14,228.46 crore. Operating margin improved to 59.94% from 52.81%, helped by a larger deposit base and steady loan growth.
Foreign institutions hold 36.66% and domestic institutions 24.60%. At Rs 86.05 the stock trades at a P/E of 24.74 and 1.51 times book value. Return on equity is 6.11%, still below most peers, so continued profit growth is needed to lift returns. The stock is part of the F&O segment.
Screen Stocks by Quarterly Profit Growth on the Univest Screener
3. Morepen Laboratories: Q2 FY27 Profit Up 116.6%
Morepen Laboratories grew Q2 FY27 profit by 116.6% to Rs 88.89 crore on revenue up 81.4% to Rs 755.19 crore. Operating margin rose to 17.66% from 14.86%, and profit was also 57.7% higher than the June 2026 quarter.
The company makes active pharmaceutical ingredients, diagnostic devices and consumer health brands. At Rs 90.55 it trades at a P/E of 26.35 against a pharma industry P/E of 40.13, with a debt-to-equity ratio of 0.23. FY26 profit was lower than FY25, so the FY27 rebound needs to carry through the rest of the year.
4. SJVN: Q2 FY27 Profit Up 113.7% as New Plants Start
SJVN’s Q2 FY27 profit rose 113.7% to Rs 657.72 crore and revenue rose 112.4% to Rs 2,290.31 crore, as newly commissioned capacity began contributing during the strong monsoon generation season.
The government holds 55.0% and the Government of Himachal Pradesh 26.85%. At Rs 56.20 the stock trades at a P/E of 22.30 and pays a 2.67% dividend yield. Debt-to-equity is 2.25 because of heavy project investment, so interest costs will shape how much of the revenue growth reaches profit in coming quarters.
Download the Univest iOS App or Univest Android App to track these stocks live and get daily research.
Why Q2 FY27 Profit Growth Matters for Investors
Strong Q2 FY27 profit growth can signal a turning point in a company’s earnings cycle. When revenue and margins rise together, as they did at Manali Petrochemicals and Morepen, the improvement is more likely to continue than when profit rises from one-time items.
Earnings momentum often draws institutional buying over the following quarters. Comparing these stocks with a broad index like the BSE 500 shows whether their gains are company-specific.
How to Read Quarterly Results Before Buying
- Check revenue alongside profit: Profit growth without revenue growth is less reliable.
- Compare the same quarter: Year-on-year comparisons remove seasonal effects, important for SJVN.
- Watch operating margin: Rising margins show pricing power or cost control.
- Look for one-time items: Tax credits or asset sales can inflate a single quarter.
- Track the next two quarters: One strong result is a signal, three make a trend.
Points to Be Careful About
- Low base effect: Some growth percentages look large because the year-ago quarter was weak.
- Cyclical pricing: Manali’s margins depend on petrochemical prices.
- Debt at SJVN: Higher interest costs could slow profit growth.
How to Invest in Stocks With Strong Quarterly Results
- Use the Univest Screener to filter stocks by quarterly profit growth.
- Confirm revenue and margin trends support the profit jump.
- Compare valuation with industry averages.
- Wait for confirmation in the next quarterly result if unsure.
- Invest through a SEBI-registered broker such as Univest, in stages.
Conclusion
Manali Petrochemicals, IDFC First Bank, Morepen Laboratories and SJVN each more than doubled Q2 FY27 profit, with strong revenue growth behind the gains. Manali offers the lowest valuation, IDFC First Bank the largest scale, Morepen a pharma rebound, and SJVN capacity-led growth. The next two quarters will show whether this momentum is lasting. Consult a SEBI-registered advisor before investing.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Q2 FY27 Profit Growth Stocks
Which stocks under Rs 100 doubled profit in Q2 FY27?
Ans. Manali Petrochemicals, IDFC First Bank, Morepen Laboratories and SJVN more than doubled Q2 FY27 profit compared with the September 2025 quarter. Manali’s profit rose 249.9%, IDFC First Bank’s 201.7%, Morepen’s 116.6% and SJVN’s 113.7%. Revenue grew at least 20% at all four, showing the growth came from business expansion rather than one-time items.
Why did IDFC First Bank’s Q2 FY27 profit triple?
Ans. IDFC First Bank’s Q2 FY27 profit rose 201.7% to Rs 1,049.17 crore as revenue grew 20.3% and operating margin improved to 59.94% from 52.81%. A larger deposit base and steady loan growth supported the improvement. The year-ago quarter was also relatively weak, which adds to the growth percentage. Return on equity remains at 6.11%, so continued gains are needed.
Is Manali Petrochemicals’ profit growth sustainable?
Ans. Manali Petrochemicals’ Q2 FY27 profit rose 249.9% on revenue growth of 58.8% and an operating margin of 24.73%. Its products are cyclical, so margins can change with raw material and selling prices. FY26 profit had already risen 343.4%. The stock trades at a P/E of 5.91, which partly reflects this cyclicality. Tracking margins over the next few quarters will show whether the gains hold.
What drove SJVN’s revenue growth in Q2 FY27?
Ans. SJVN’s revenue rose 112.4% to Rs 2,290.31 crore in Q2 FY27 as newly commissioned power capacity started contributing during the monsoon season, when hydro generation is highest. Profit rose 113.7% to Rs 657.72 crore. Its debt-to-equity ratio of 2.25 means interest costs will influence how much of future revenue growth turns into profit.
Should I buy a stock after one strong quarter?
Ans. One strong quarter is a useful signal but not enough on its own. Check whether revenue and margins support the profit growth, whether there are one-time items, and how the stock is valued against peers. Many investors wait for a second strong quarter to confirm the trend, or buy in stages. Consult a SEBI-registered advisor for advice suited to your goals.
What is a low base effect in quarterly results?
Ans. A low base effect happens when the year-ago quarter had unusually weak results, making the current quarter’s growth percentage look very large. For example, a profit rising from Rs 10 crore to Rs 30 crore is 200% growth, even though the absolute increase is modest. Always look at the absolute numbers and multi-quarter trends alongside growth percentages.